3D Cell Culture Market worth $1,846 million by 2024
What is the future growth analysis of global 3D
Cell Culture Market?
The 3D
cell culture market is
expected to reach USD 1,846 million in 2024 from USD 892 million in 2019
growing at a CAGR of 15.7%What are key factors driving growth of
global 3D Cell Culture Market?
The growth of this market is driven mainly by the increasing focus on
developing alternatives to animal testing, growing focus...
3D Cell Culture – An Emerging Market with Attractive Growth Opportunities
Globally, the 3D cell culture market is witnessing high growth due to factors such as rise in research and development investments, higher adoption, use of microfluidic technology, increasing focus on regenerative medicine, and use of 3D cell culture models for drug discovery and toxicology in vivo testing. In addition, rapid increase in the need for organ transplantation is further expected to...
3D Cell Culture Market | Latest Opportunities and Emerging Trends
Globally, the 3D cell culture market is witnessing high growth due to factors such as rise in research and development investments, higher adoption, use of microfluidic technology, increasing focus on regenerative medicine, and use of 3D cell culture models for drug discovery and toxicology in vivo testing. In addition, rapid increase in the need for organ transplantation is further expected to...
How Top Companies In 3D Cell Culture Market Expanding Their Presence In Global Market
The 3D cell culture market is expected to reach USD 1,720.3 Million by 2022 from USD 682.8 Million in 2017, at a CAGR of 20.3%. Factors such as the rising focus on developing alternative methods for animal testing, funding initiatives from government and private investors, technological advancements and product launches, and growing awareness are driving the growth of this market.Agreements, partnerships,...
3D Cell Culture Market | Revenue Growth Strategies Adopted by Leading Companies
Thermo Fisher (US) and Corning (US) are the Leading Player in the 3D Cell Culture Market
The 3D cell culture market is expected to reach USD 1,720.3 Million by 2022 from USD 682.8 Million in 2017, at a CAGR of 20.3%. Factors such as the rising focus on developing alternative methods for animal testing, funding initiatives from government and private investors, technological...
3D Cell Culture Market | Thermo Fisher (US) and Corning (US) are the Leading Player in Market
The 3D cell culture market is highly competitive with several big and small players. Prominent players in this market include Thermo Fisher (US), Corning (US), Lonza (Switzerland), Merck (Germany), ReproCELL (Japan), and InSphero (Switzerland). The other players operating in this market include Global Cell Solutions (US.), Synthecon (US), 3D Biotek (US), Kuraray (Japan), Hamilton Company (US), Mimetas...
Thermo Fisher (US) and Corning (US) are the Leading Player in the 3D Cell Culture Market
The 3D cell culture market is expected to reach USD 1,720.3 Million by 2022 from USD 682.8 Million in 2017, at a CAGR of 20.3%. Factors such as the rising focus on developing alternative methods for animal testing, funding initiatives from government and private investors, technological advancements and product launches, and growing awareness are driving the growth of this market.
Agreements, partnerships,...
What will be the advancements in products of 3d cell culture to impact the global 3D Cell Culture Market.
The global 3D cell culture market is projected to reach USD 1,720.3 Million by 2022 from USD 682.8 Million in 2017, at a CAGR of 20.3%. Factors such as rising focus on developing alternative methods for animal testing, funding initiatives from government and private investors, technological advancements and product launches, and growing awareness are driving the growth of the market.
...
Increasing adoption of 3D cell culture technique in drug discovery is fueling the growth of 3D cell culture market
Globally, the 3D cell culture market is witnessing high growth due to factors such as rise in research and development investments, higher adoption, use of microfluidic technology, increasing focus on regenerative medicine, and use of 3D cell culture models for drug discovery and toxicology in vivo testing. In addition, rapid increase in the need for organ transplantation is further expected to propel...